Pharmacokinetic Properties of Fast-acting Insulin Aspart Administered in Different Subcutaneous Injection Regions: Response to the commentary by Nuggehally R. Srinivas
Crossref DOI link: https://doi.org/10.1007/s40261-017-0539-7
Published Online: 2017-06-08
Published Print: 2017-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Heise, Tim
Hövelmann, Ulrike
Nosek, Leszek
Sassenfeld, Bettina
Thomsen, Karen Margrete Due
Haahr, Hanne
Funding for this research was provided by:
Novo Nordisk (DK)
License valid from 2017-06-08